ISQ Global Fund II GP LLC (Wahba Sadek, Bhandari Gautam) sold $3.7M of KNTK (indirect holdings)
ISQ Global Fund II GP LLC sold 68,005 indirectly-held shares of Kinetik Holdings Inc. (KNTK) at an average of $54.36 ($54.32–$55.07, $3.70M total) across 3 trades over 2026-08-18 to 2026-08-20. Filed jointly with I Squared Capital, LLC (10% owner), ISQ Holdings, LLC (10% owner), Wahba Sadek (10% owner) and Bhandari Gautam (10% owner).
How this was made
The 30-second read
Why it matters
The disclosed sale may influence short‑term trading sentiment but is unlikely to drive long‑term price movement.
Market read
Primary insider sale provides new data for traders monitoring KNTK; limited broader market impact.
What to watch
The insider still retains a large stake (over 925k shares) and the sale was executed via multiple small trades, indicating possible liquidity management.
Background
Form 4 filings disclose insider transactions and are considered primary sources of material information.
Ticker impact
ISQ Global Fund II GP LLC sold $3.7M of KNTK shares (68,005 shares) via open‑market transactions on 2026‑08‑18 to 2026‑08‑20.
Possible short‑term dip of 1‑2% as the market digests the insider sell.
While the transaction size is relatively small for the market, it is a primary Form 4 filing and the insider holds a 10% stake, making the sale noteworthy for traders.
Market effects
Minimal impact on the broader biotech sector; the sale is company‑specific.
No significant regional effect; limited to investors tracking KNTK.
Low global relevance.
Counterpoint
The sale could be a routine portfolio rebalancing rather than a negative signal, suggesting the stock may be undervalued.
Key entities
- companyKinetik Holdings Inc.
US‑listed biotech firm (ticker KNTK).
- insiderISQ Global Fund II GP LLC
10% owner of KNTK reporting the sale.
